| Product Identification | |
|---|---|
| Product Name | 5-Bromo Benzofuran |
| IUPAC Name | 5-Bromo-1-benzofuran |
| Chemical Formula | C8H5BrO |
| Synonyms & Trade Names | 5-Bromobenzofuran, 5-Bromo-1-benzofuran |
| HS Code & Customs Classification | 2932.29 (Heterocyclic compounds with oxygen hetero-atom(s) only) |
Our technical teams approach the production of 5-Bromo Benzofuran by weighing process route options that balance cost-control, scalability, and purity. Raw material selection directly impacts impurity load downstream, with bromination step control ranked as a key point for both batch-to-batch color and assay uniformity.
Most internal quality criteria target consistent appearance, minimal halide byproduct, and a clear spectral match. Depending on end-user and application needs—for instance in pharmaceutical synthesis versus materials R&D—acceptable ranges for trace impurities, particle morphology, and lot packaging size can differ sharply. Release standards are defined through joint agreement with downstream users and refined following each campaign’s analytical results.
During scale-up and customer qualification, technical support teams adjust process parameters to meet the specific synthesis or formulation requirements. Custom impurity profiling or purification strategies may be requested for regulated sector projects, which dictates tailored batch documentation and, in some cases, gate release testing per shipment.
5-Bromo Benzofuran manufactured in our facility typically presents as a crystalline or powdery solid. The actual color often shows off-white to pale beige tones; trace impurities or process conditions may slightly deepen the appearance. Mild aromatic odor can arise depending on handling method and batch homogeneity.
Solid form selection for packaging and downstream conversion caters to stability and dust minimization. Melting and boiling points, as well as flash point, cannot be quoted universally due to grade and purity sensitivity—formulation chemists often request these values for specific grades, and data depends on analytical reference used.
Industrial grade density lies within the general range for aryl bromides, but precise values tie directly to crystalline form and moisture content at packaging. These characteristics influence dosage, dissolving time in formulation, and process safety during transfer.
Benzofuran rings substituted with bromine remain stable under standard warehouse conditions typically used for aromatic heterocycles. Prolonged heat or extended light exposure will slowly cause discoloration, possible resin formation, and tend to increase impurity levels, especially in open containers or with atmospheric moisture infiltration.
Container integrity and material choice (such as amber glass or lined drums) control stability especially over extended storage or multiple handling cycles.
Solubility of 5-Bromo Benzofuran varies widely by grade and particle size. Most process and analytical workflows rely on dissolution in halogenated or aromatic solvents such as dichloromethane, chloroform, or toluene. Limited water solubility is typical, so technical teams often pre-dissolve the material before dosing into aqueous synthesis steps.
Solution preparation protocols depend on batch-to-batch purity and intended use: pharmaceutical application may demand sterile filtration; industrial intermediate settings only require gross dissolution and sediment elimination.
Our commercial offering encompasses several grades, determined by downstream requirements. Analytical purity, moisture content, residual solvent profile, and color index are the most scrutinized parameters. Detailed tables are prepared in cooperation with client specifications and can reflect differences originating from synthesis batch size or route.
For precise pharmaceutical synthesis, specifications are more stringent, covering organic volatile impurities and trace element monitoring. Technical applications may accept wider impurity bandwidths. Our internal tables get updated per quality management review and industry regulatory shifts.
Impurity control centers around brominated regioisomers, unreacted starting material, and process-related halide byproducts. Process optimization aims at minimizing heavy metal and colored or unstable side-products, which, if present above specification, provoke corrective purification or batch rejection.
Impurity limits tie directly to customer process tolerance and end-use application standards and are only set after analytical trend study over production campaigns.
Standard determination of quality properties uses a set of validated techniques: GC-MS for organic volatile impurities, HPLC for purity checks, Karl Fischer titration for moisture, and visual/colorimetry for color grading. Where applicable, method adaptation to suit customer SOPs is provided; batch release occurs only after full panel conformity to mutually agreed specifications.
Reliable raw material sourcing drives batch reproducibility. Halogenating agents and benzofuran ring precursors are selected from vetted suppliers, prioritizing consistent impurity fingerprint and logistically stable delivery. Any change in critical raw material source triggers requalification.
Synthesis route generally involves electrophilic bromination on the benzofuran core. Selection of bromination agent and reaction medium hinges on desired selectivity, impurity generation control, and cost efficiency. Process development teams periodically re-validate the reaction pathway as regulatory or cost constraints shift.
Typical variations in route arise between pharmaceutical and technical grades; pharma-bound lots frequently use milder conditions and more refined raw inputs, demanding stricter impurity abatements earlier in the route.
Key control points include reaction exotherms, pH, and timing of quench. Side-product minimization dictates the cooling profile and extraction protocol. Purification step—typically crystallization, with or without solvent exchange—directly impacts final physical appearance, impurity residuals, and overall yield.
Batch processing units monitor in-process composition using direct analytical sampling; any off-specification results prompt immediate rework or discard protocols to sustain product reliability across campaigns.
Final QC comprises both in-house method panel and targeted checks for any customer-specific test request. Only conforming lots progress to packing and release. Batch-to-batch consistency draws from process validation records that tie back to raw material origin, process run parameters, and analytical sign-off.
5-Bromo Benzofuran acts as a strategic intermediate for cross-coupling, such as Suzuki or Stille transformations. The position-selective bromine supports further substitutions, allowing preparation of a range of diversified benzofuran scaffolds.
Typical modification employs palladium-based catalysis, base additives, and polar aprotic solvents at temperatures from ambient to moderately elevated levels. Reaction outcomes show sensitivity to catalyst load and batch mixing efficiency, with the starting purity dictating ease of downstream isolation.
Commercial clients target advanced benzofuran derivatives for applications in pharma, electronic materials, or specialty chemicals. End-user demands determine if additional purification or isomer separation steps are performed prior to shipment.
Storage for 5-Bromo Benzofuran benefits from cool, dry conditions, minimizing exposure to direct sunlight and moisture ingress. Drums and containers must provide an adequate barrier to atmospheric gases; inert gas blanketing is sometimes applied for highly sensitive or research grades.
Suitable container choices include lined steel drums or amber glass bottles for laboratory scale. Compatibility checks ensure absence of interaction with liners or gasket materials, especially over prolonged storage cycles.
Shelf life reflects initial purity and storage discipline. Product quality reviews—visual, analytical—detect discoloration, clumping, or off-odors as signs of degradation. Shelf life specification follows stability trend data and customer risk tolerance; higher-grade applications demand stricter shelf life assurance than technical-grade use-cases.
Hazard classification adheres to the most recent global and regional GHS updates for substituted aromatic compounds. Labelling and shipping obligations reflect assessed risks tied to acute toxicity, environmental hazards, and irritant potential.
Precautionary statements derive from measured laboratory handling incidents and epidemiological database review. Recommendations prioritize avoidance of inhalation and skin contact, suitable engineering control in larger scale handling, and correct PPE for anticipated exposure level.
Acute and chronic toxicity data, when available, receives periodic review with batch-release documentation. As a brominated aromatic, it is handled as a substance of moderate concern in occupational scenarios, guided by laboratory, pilot, and full-scale process learnings.
Exposure limit values align to regulatory and local occupational health recommendations. Technical staff calibrate handling protocols per plant area and operation—closed-system handling predominates, with secondary containment and exhaust ventilation at key transfer points. Spill and accidental release preparation forms part of standard operator training.
Continuous batch production delivers a stable supply of 5-Bromo Benzofuran for both pharmaceutical intermediate and specialty material applications. Actual output depends on raw material schedules and customer order aggregation. Supplies across pharmaceutical and technical grades follow customer-driven batch release, not open-market speculation. Production scaling or interruptions track sourcing of bromine donors and benzofuran feedstock, which represent the core procurement dependencies.
Standard lead times fall within 3-5 weeks from order confirmation, subject to full-specification alignment. Minimum order quantities adjust based on container and grade, with kilogram-scale as baseline for technical grade and higher for regulated (pharmaceutical) use. Urgent or prepacked supply options exist by prior process scheduling, but grade transitions in cleaning and setup time influence responsiveness.
Packaging employs HDPE drums, UN-approved fiber drums, or amber glass bottles, depending on volume, purity requirements, and sensitivity to light or air. Pharmaceutical-grade product requires inert packaging with validated tamper evidence and moisture protection. Custom secondary packaging is available, conditioned on prior qualification.
Shipping accepts both sea and air freight, with temperature, shock, and humidity conditions mapped to the impurity profile risks of each batch. Payment terms reflect destination, customer status, and compliance demands; LC, TT advance, or net-offset arrangements exist but hinge on the regulatory context of end use and batch certification status.
Material cost peaks with brominating agents and functional benzofuran precursors. Upstream fluctuations, especially in bromine supply and fossil-based aromatic compounds, create most shifts in quoted price. Conversion cost includes waste management of halogen residues and energy for low-temperature operations. Product grade—technical, regulated intermediate, or high-purity—directly alters cost via purification load, QA/QC protocol, and labor intensity.
Raw material shifts often follow policy changes in bromine extraction regions, refinery run rates impacting aromatic feedstocks, and environmental surcharges on halogenated by-products. Price instability is intensified by seasonal energy costs and freight disruptions. Regulatory tightening in exporter countries raises compliance cost and can delay feedstock shipments, driving up finished material pricing.
Product price spreads track the technical depth of analysis and batch authentication. Higher purity and stricter impurity thresholds require dedicated purification, which increases both direct cost and unavoidable yield loss. Packaging with full track-and-trace, serialization, or validated pharmaceutical logistics initiates surcharges over standard chemical trade. Certification barriers (e.g., GMP, DMF submission) are reflected as grade-specific cost upcharges.
Current demand clusters in generic pharma manufacturing (notably for CNS actives and intermediate exports) and niche electronics chemicals. Asia leads in production volume due to cost control and proximity to both bromine pools and aromatic plants. Western buyers show preference for certified higher grades, shifting some volume to stricter contract manufacturing.
US and EU customers base procurement on regulatory compliance and batch release verification. Japan imposes documentation-heavy supplier audits with traceable chain-of-custody. India and China maintain price-driven demand but face periodic tightening as local environmental controls disrupt upstream chemical synthesis. Consistent supply hinges on the producer’s ability to isolate batch splits, validate impurity drift, and adjust route for both pharma and technical grade use cases.
Raw material pricing volatility shapes the 2026 outlook, with upward pressure expected due to environmental bottlenecks in bromine and fossil feedstocks, as well as regulatory compliance costs in China and India. Price stabilization depends on raw material contract hedging and expanded purification recovery efficiency. Tiered price structures—by grade, batch certification, and packaging compliance—will dominate contract terms, with 2026 average prices predicted to climb in line with escalated QC and logistics requirements, particularly in regulated economies.
Forecasts integrate in-house production cost histories, customer batch release data, raw material contract indices, and published trends from industry regulatory filings and import/export logs. Analytical weighting prioritizes supply consistency, regional policy change, and impurity penalty cost.
Recent months have seen stricter halogen emission standards in key bromine and benzofuran manufacturing zones. Producers report increased batch rejection rates and forced upgrades to in-process scrubbing and off-gas capture. Policy-driven energy cost inflation compounds purification curve expense for high-purity lots.
GMP and EU REACH enforcement pressure expands. Hazard profile review cycles for aromatic bromides lead to continuous dossier updates. Supply for pharmaceutical uses in regulated markets requires full impurity mapping and enhanced secondary containment validation in transit.
Manufacturers implement enhanced real-time impurity monitoring and invest in modular batch purification upgrades that allow split-level grade control without cross-batch contamination. Raw material dual-sourcing stabilizes lead times and buffers peak-price periods. Regulatory compliance teams dedicate additional technical support for customer audit trails and certification filings.
In industrial settings, 5-Bromo Benzofuran supports multiple downstream sectors. The pharmaceutical industry draws on it as a core intermediate in the synthesis of bioactive molecules, often where specific halogen placement is required on a benzofuran scaffold. Agrochemical developers also rely on selective halogenation for lead optimization. Specialty chemical producers may introduce it into materials or dyes where electron distribution or optical properties need tuning.
Each industry approaches specification development based on end-use performance and trace impurity sensitivity. The route selected during manufacturing, coupled with the grade, directly influences suitability for each sector.
| Industry Segment | Typical Grade | Key Properties for Use |
|---|---|---|
| Pharmaceutical Intermediates | High-Purity, Low-Metal | Minimal halogenated byproducts, tight controls on metal content, color acceptance within strict range, batch-to-batch reproducibility |
| Agrochemical Synthesis | Technical Grade | Focus on total organic impurity threshold, selective residual solvents, functional stability in aggressive downstream steps |
| Specialty & Fine Chemicals | Technical or Custom Purity | Optimized for reactivity, solvent compatibility, absence of interfering aromatic impurities, customizable color and odor thresholds |
Grade selection hinges on critical performance aspects. Pharmaceutical producers flag polar contaminants and require full impurity traceability aligned with regulatory filings. Agrochemical processors generally tolerate a broader impurity profile but must manage residual active halides impacting downstream activity. Fine chemical formulators often request adjusted moisture or ash levels, especially where subsequent polymerization or coupling reactions run solvent-free.
Clarify the intended downstream use. A pharmaceutical synthesis path typically imposes more demanding impurity and trace metal profiles than a dye synthesis route. Knowing the endpoint drives all specification work-up.
Local and end-market regulations determine which trace impurities and toxicological limitations require control. For pharmaceutical supply chains, current GMP and ICH guidelines push for comprehensive documentation and validated cleaning protocols at each step. Agrochemical and industrial users align their standards with final product submission requirements or internal acceptance limits.
Define the maximum accepted limits for total impurities, residual solvents, and specific metal traces. In pharmaceutical-grade material, major bodies scrutinize every impurity above 0.1%. Technical grades, by contrast, prioritize conversion efficiency and cost-effectiveness but still require full traceability on any persistent manufacturing byproducts.
Annual volume targets affect process selection, packaging options, and available grades. Smaller scale, high-purity needs increase per-unit cost due to more frequent batch changes and analytical checks, while technical-grade production for commodity use benefits from continuous process optimization.
Before locking in supply, sample validation on actual process equipment confirms real-world performance. Several customers conduct side-by-side comparisons of chromatographic purity, melting range, or spectral consistency. Stability during storage and in-process handling is best checked under operating conditions rather than relying solely on generic shelf life claims.
Feedstock for 5-Bromo Benzofuran is often sourced based on bromo-content uniformity and controlled trace chlorides. Selection addresses cost-performance balance and downstream impurity risk.
Manufacturers select halogenation strategies and oxidative conditions according to the scale, desired selectivity, and ease of in-process controls. Regioselectivity, solvent load, and heat management guide the decision between batch and flow operations.
Critical parameters include brominating agent feed rate, temperature control at the coupling step, and maintaining water content within set limits. Deviations may result in side reactions, raising levels of dibromo impurities or incomplete conversion.
Most observed impurities stem from over-bromination, residual solvents, and byproducts of starting material oxidation. The purification train—crystallization, recrystallization, or chromatographic steps—varies with grade designation and is confirmed by process-specific analytical runs.
Each production batch undergoes in-process chromatography and spectroscopic analysis at control points defined by internal procedures. Final release references batch data against agreed standards for purity, color, and assay. Consistency checks flag any drift in impurity profiles, linking observations back to raw material lots or process changes.
Material is approved for shipment only when it meets all parameters established with the customer or per regulatory registrations. Specifications reflect actual manufacturing capability, validated through routine trend analysis and change management protocols.
In producing 5-Bromo Benzofuran, our plant runs under a quality system shaped by internationally recognized standards. We built our quality management based on continual risk assessments for impurity profiles, change control logs for process parameters, and regular internal audits. Documentation gets maintained for every critical manufacturing step—starting from raw material traceability, through every stage of synthesis and purification, to final QC release. Our process yields detailed batch records and deviation analyses, which are always subject to third-party review during client quality audits.
Certifications tailored for 5-Bromo Benzofuran can be provided once end-use or regulatory region is defined. We adapt our control parameters and analysis protocols to align with customer requirements for pharmaceutical, agrochemical, or fine chemical use. Certificates of Analysis always reflect the release standards based on agreed methods. If customers require specific statements on residual solvents, elemental impurities, or compliance with national inventories, these are declared according to the product grade and latest available testing.
Each batch dispatch includes a full documentation package containing Certificate of Analysis, synthetic route overview, analytical reports, and—where required—stability profiles and transport safety assessments. Custom reports, such as impurity mapping or extended release testing, can be generated after consultation regarding the intended application or downstream integration risks. All QC testing is referenced to protocols defined during initial customer qualification unless updates are mutually agreed during ongoing cooperation.
Our 5-Bromo Benzofuran operations are structured for stable, scalable output. We track core production capacity against standing and forecasted orders. Before committing to supply contracts, we outline expected demand patterns, verify raw material continuity, and model proactive process scheduling. This approach minimizes the risks of batch interruptions or allocation delays, ensuring sustained output even during tight market windows or supply chain disturbances. Flexible cooperation applies in volume contracting or phased deliveries—customers may secure batch reservations, call-off quantities, or conversion from spot to rolling agreements, with scheduling based on real-time production status.
Process scale-up leverages dedicated reactor setups and validated cleaning protocols for every changeover to another grade or product family. Key control points, including bromination yield, by-product purge, and final purification step, remain under continuous in-process verification to suppress cross-batch variability. Actual volume per month varies by campaign plan and customer allocation, communicated in regular production snapshots. Supply reliability directly links to our ability to forecast raw material lead times and buffer critical intermediates when market stress is anticipated.
Sample requests follow a defined application workflow. The lab-scale or commercial batch reference, targeted end-use, and most relevant specification must be confirmed up front. Quality and impurity data sets, as well as handling and storage recommendations, match the intended application—be it reference testing, formulation feasibility, or validation protocols. Lead times for sample shipment are subject to available safety stock and documentation finalization for the required grade.
Business models reflect both spot and contract-based frameworks. Volume flexibility, change of order schedule, and joint forecast reviews form the backbone of cooperation—supported by real-time batch status reporting and production window booking. Modifications to product specifications or packaging formats are discussed during annual supply meetings or as part of ongoing technical support sessions. Longer-term partners can request dedicated capacity campaigns or adjust order frequency as actual demand is clarified, provided sufficient production horizon is available for replanning. This level of flexibility reduces lead time risk for downstream users managing dynamic or seasonal requirements.
Current research in our manufacturing teams focuses on refining bromination selectivity and minimizing by-product formation during 5-bromo benzofuran synthesis. Choice of bromination reagent and reaction conditions (temperature, solvent, additive profile) plays a significant role in controlling electrophilic substitution on the benzofuran ring. Directing regioselectivity remains a challenge, especially in large-batch processes where heat transfer and mixing must be balanced for consistent product output. Analytical development targets real-time monitoring of product purity and residual starting material, supporting process improvements and end-point determination.
In the pharmaceutical sector, 5-bromo benzofuran serves as a key intermediate in heterocyclic drug synthesis. Recent industry requests point to utilization in target molecules related to central nervous system agents and kinase inhibitors. Some agrochemical developers express interest in this scaffold due to its potential for substitution and further derivatization, which offers flexibility during lead optimization. Fine chemical users frequently request product with controlled impurity profiles to facilitate downstream metal-catalyzed coupling or cyclization processes. Application scope expands as downstream chemists look for non-chlorinated halogenated aromatics to optimize synthesis routes.
Key technical issues in industrial production include suppression of dibromo and polybrominated side-products, which complicate purification and reduce yield. In-process impurity control relies on phase separation efficiencies and post-reaction quenching protocols. Breakthroughs have come from optimizing reagent addition rates and adopting continuous flow bromination in pilot-scale systems, which delivers tighter control on reaction exotherms and by-product levels. Our teams focus on grade-specific purification regimes; pharmaceutical-grade material typically requires tighter limits on residual solvents and trace halogen content compared to agrochemical grades.
Market demand projections for 5-bromo benzofuran align with the uptick in heterocyclic building block demand from both pharma and agrochemical sectors. Customers lean toward custom synthesis and contract manufacturing options to manage complex supply chains. Most growth is expected among end-users developing high-value active pharmaceutical ingredients and specialty chemicals that integrate bromo-substituted aromatics for further derivatization. Bulk demand for standard grades remains steady, but grade diversification, especially for high-purity and low-residual solvents, is an increasing trend.
Synthetic route improvements focus on solvent recycling and catalyst recovery. Some pilot programs investigate solvent-free bromination, though industrial scale-up presents throughput and mixing challenges. In downstream processing, manufacturers invest in semi-automated crystallization and vacuum drying to enhance batch-to-batch consistency. Companies are validating in-line analytics such as NMR or HPLC for real-time monitoring to drive process digitalization and limit manual sampling.
Our direction involves continuous improvement in waste reduction and safe handling of brominating reagents. Shifts toward greener bromine sources and solvent recovery strategies reduce hazardous effluent. Raw material assessment gauges vendor adherence to environmental standards, and regional regulatory influences guide the adoption of non-chlorinated solvents and energy-efficient processes. In response to customer sustainability objectives, the technical team evaluates sources and disposal methods for spent reagents—adjusting protocols according to local environmental regulations and client-specific requirements.
Our technical service team provides support for synthetic route design, identification of process bottlenecks, and selection of the appropriate grade based on end-use regulatory requirements. Field experience includes troubleshooting bromination selectivity in customer pilot plants and tailoring impurity control strategies for downstream catalytic transformations. Specific advice addresses handling protocols for moisture-sensitive or high-reactivity grades, focusing on compatibility with existing plant equipment and regulatory frameworks.
We assist customer R&D teams with analytical method transfer, guidance on solvent-switching, and scale-up risk management. Through collaborative development, we recommend purification schemes or alternative processing methods for applications that require minimal residual starting material or tight particle size distribution. For new molecule development, the team offers insight on downstream derivatization compatibility, with specific attention to common issues such as halide displacement or side-reactions.
Batch-to-batch consistency is managed through systematic release testing according to customer-defined or industry guidelines. Ongoing quality tracking involves stability studies, with in-market feedback loops used to adapt in-process controls or packaging methods. In cases where shipments experience unforeseen issues (e.g., on-storage crystallization or color changes), our team engages directly with the customer's technical staff to diagnose and resolve root causes, documenting learnings for continual improvement.
| Key Area | Manufacturer's Approach |
|---|---|
| Raw Material Selection | Consider grade, reactivity profile, and supplier traceability; select for low inorganic contaminants and batch history compatibility with process route. |
| Process Route Selection | Compare batch vs. continuous flow for bromination; factor in yield, by-product profile, heat transfer limits, and scalability. |
| Impurity Control | Focus on minimizing dibromo/polybromo content; deploy staged purification for pharmaceutical applications; track residual solvent based on downstream customer specs. |
| In-Process Control | Utilize real-time analytical QC during reaction and workup; adjust process parameters based on intermediate purity and customer specs. |
| Batch Consistency | Release standards depend on product grade, application, and customer requirements. Internal QC monitors by GC, HPLC, or NMR as defined by application needs. |
Our plant manufactures 5-Bromo Benzofuran using a controlled synthesis designed for repeatable large-batch output. This approach streamlines scale-up for industrial systems and improves lot traceability. Each stage, from raw material selection to final purification, gets tracked by an in-house team with years of experience handling halogenated benzofuran chemistry. Continuous investment in process equipment and analytics allows reliable output with consistent physical and chemical properties.
5-Bromo Benzofuran supports a variety of downstream syntheses in pharmaceuticals, agrochemicals, and functional organic materials. As a brominated intermediate, it integrates smoothly into further halogen exchange, cross-coupling, and side-chain modification processes. Industrial R&D teams have leveraged this molecule for active ingredient building blocks, novel ligands, and advanced material prototypes. Our technical staff works closely with formulation and pilot teams at customer sites for efficient technology transfer and upscaling.
Process control at every step keeps the impurity profile stable and ensures compliance with pre-agreed quality ranges. Inbound raw materials undergo verification through established supplier audits and analytical checks. Inline instrumentation and batch testing cover purity, residual solvents, color, and physical form. We document every batch to meet audit requirements. Batch-to-batch reproducibility reduces risk for downstream users and simplifies their own QC routines.
Packaging choices depend on end-user requirements but always aim at minimizing handling loss and moisture ingress. Fittings, liners, and closures match the reactivity of the compound to maintain shelf-life during extended storage. Dedicated logistics teams coordinate scheduling to align with just-in-time mandates and consolidated shipments. With a robust inventory buffer and regional warehousing, we maintain supply continuity—even during spikes in demand or transport disruptions.
Industrial chemists and process engineers can access our technical resources for help with integration or troubleshooting. Support goes well beyond simple paperwork or basic usage tips. Senior scientists provide insights into reactivity, impurity control, and scale-up behavior based on production experience. In-house labs and pilot reactors accommodate joint work on custom synthesis or application trials, reducing the gap between R&D and routine manufacture.
Direct cooperation with the production source brings measurable supply security, transparency, and technical backup. Contract terms address volume planning, predictable pricing, and documentation traceability. Procurement teams lower sourcing risk and avoid mark-up layers by securing product from the original maker. Distributors benefit from streamlined logistics and competitive lead times for local market service. End manufacturers gain both technical feedback and early notice on any regulatory or raw material changes that may impact sourcing.
| Feature | Benefit to Industrial Clients |
|---|---|
| Factory-Controlled Production | Consistent specifications, batch traceability |
| Flexible Packing Solutions | Minimizes spillage, preserves material stability |
| Technical Consulting & Laboratory Support | Accelerates problem-solving and process optimization |
| Direct Supply Agreements | Improved pricing, predictable lead times |
| Integrated Quality Management | Simplifies regulatory audits and compliance checks |
As direct producers of 5-Bromo Benzofuran, we place strong emphasis on accurate chemical identity. Here in the factory, there’s no substitute for precise molecular weight and a well-established CAS number. These two parameters must be correct from raw material purchasing to our own finished product release. 5-Bromo Benzofuran has the verified molecular formula C8H5BrO, giving it a molecular weight of 197.03 g/mol. The CAS number is 446-53-3. We use these exact criteria in all our analytical documentation, on our production logs, and as part of every quality control batch record.
Accurate reporting of critical identifiers isn’t just about internal process control. Customers, regulators, and downstream labs all rely on us for this data. The CAS number 446-53-3 uniquely identifies 5-Bromo Benzofuran in REACH registrations, customs declarations, shipping manifests, and technical documentation. Any deviation can trigger technical misunderstandings, customs holds, or regulatory questions. For our facility, errors in chemical identity result in direct reputational and financial cost, which is why our procedures for verification run across sourcing, manufacturing, and dispatch.
From our experience, the difference between one digit in a CAS number or a misplaced decimal in molecular weight is the difference between compliance and an out-of-specification inquiry. Barcode systems, dockside checks, and finished goods verification all trace back through these primary identifiers. Our in-house chemists check every lot using gas and liquid chromatography, matching spectra to reference standards to confirm the core chemical fingerprint. Each laboratory certificate we issue connects unambiguously to 5-Bromo Benzofuran — never to a similar halogenated benzofuran or related compound.
Errors in nomenclature or identifier assignment have real supply chain consequences. Incidents can lead to misdelivery, hazardous waste misclassifications, or unintended use in synthesis. This is especially true for compounds like 5-Bromo Benzofuran, which feature closely related analogs. Our labeling and packaging team confirms printed identifiers at the point of capping and carton sealing. Routine audits of retained samples tie physical product to batch documents for clarity in any future traceability checks.
All our documentation — from certificates of analysis to SDS and logistics paperwork — lists the CAS number 446-53-3 and the exact molecular weight. Our technical support handles requests for spectral data, reference chromatograms, or additional analytical proofs, so labs and formulators get rapid answers. In any case of confusion over chemical identity, we open our records for side-by-side comparison against reference libraries or regulatory submissions to address questions directly and transparently. Providing these details from the source means customers get peace of mind in downstream processing, registration, or further synthesis.
As a direct manufacturer, we receive regular inquiries about bulk availability and procurement timelines for 5-Bromo Benzofuran. This molecule supports a range of advanced research and commercial syntheses, with applications stretching into pharmaceuticals, agrochemicals, and specialty chemicals. In our facility, we produce this compound from the raw material stage, so all aspects from synthesis, purification, and quality control stay within our control.
Every month, we run scheduled batches, and over the years, we have invested in robust reactor systems that allow us to scale output without sacrificing purity or reliability. For 5-Bromo Benzofuran, our standard batch sizes fit both kilo-lab needs and full-scale commercial demands. Typical runs accommodate requests from several kilograms up to the hundreds, based on customer consumption patterns and forecasting. This consistent output gives our partners confidence in securing a steady supply chain for ongoing or episodic requirements.
Each batch undergoes analytical verification to confirm identity and grade, since 5-Bromo Benzofuran often serves as an intermediate in fine chemical pipelines. Our infrastructure includes a solvent-recovery loop and air-handling measures, lowering waste while maintaining product integrity through packaging and logistics. As we provide factory-direct supply, our clients sidestep unnecessary markups and extended handoff times.
The actual lead time for procurement pivots on the requested quantity and current order pipeline. For orders within our routine production window—such as 10-50 kg—dispatch typically occurs within 2-3 weeks. This estimate accounts for the full production sequence: raw material weighing, synthesis, reaction monitoring, and thorough post-processing, capped by packaging in our lined drums or high-barrier containers.
Larger orders fall under scheduling for dedicated batch manufacturing. Orders above 100 kg enter a custom production slot. For these, firm delivery windows stretch to 4-5 weeks, reflecting reactor availability, safety checks, and extra analytical work. Force majeure events—like unprecedented raw material delays or facility upgrades—can shift delivery, but our track record demonstrates resilience through contingency plans and dual sourcing strategies.
Our technical team keeps the process transparent from inquiry to shipment. We can provide detailed specifications upon request, including chromatographic profiles and NMR spectra, since downstream chemists often seek full disclosure for regulatory files or patent filings. If customers require material matching a specific impurity profile, we work collaboratively to fine-tune the synthesis route or post-synthetic purification step.
We maintain inventory buffers for key customers, especially those with annual contracts or scheduled draws. This foresight helps offset market fluctuations in demand or logistical backlogs at ports. For projects needing expedited delivery, our plant operations can sometimes advance slotting, compressing standard lead times, provided raw materials and safety constraints allow.
Direct manufacturing enables long-term procurement strategies. Partners sharing their projections early experience smoother just-in-time deliveries and prioritized allocation in tight market cycles. Our business model rewards transparency and frequent communication: by knowing our output and scheduling capacity, customers can align their downstream launches or tech transfers without shutdown risk.
5-Bromo Benzofuran remains a specialty intermediate with cyclical demand patterns, but our plant’s design delivers flexibility. By controlling each stage from synthesis to shipment, we ensure each order—large or small—receives the same technical rigor and service commitment.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales2@liwei-chem.com, +8615380400285 or WhatsApp: +8615380400285
